1-Methylpiperazine → N-[5-(4-methylpiperazin-1-yl)pyrazin-2-yl]acetamide

HRID 203

Reaktionsgleichung

Reaktionsgleichung von HRID 203
CC(=O)Nc1cnc(Br)cn1.CN1CCNCC1>CC(C)(C)P(C(C)(C)C)C(C)(C)C.CC(C)(C)[O-].CN(C)C=O.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.[K+].[Pd].[Pd]>CC(=O)Nc1cnc(N2CCN(C)CC2)cn1

Komponenten

7

Reaktionsbedingungen

Temperatur
120 °C

Versuchsvorschrift

1-methylpiperazine (2.318 g, 23.14 mmol), N-(5-bromopyrazin-2-yl)acetamide (1 g, 4.63 mmol), tri-tert-butylphosphine (1.873 g, 9.26 mmol), tris(dibenzylideneacetone)dipalladium (0.085 g, 0.09 mmol) and potassium 2-methylpropan-2-olate (1.039 g, 9.26 mmol) were suspended in DMF (9.26 ml) and sealed into a microwave tube. The reaction was heated to 120 °C for 40 minutes in the microwave reactor and cooled to RT. The mixture was diluted with methanol and acidified with HCl, then the solution was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford N-(5-(4-methylpiperazin-1-yl)pyrazin-2-yl)acetamide (0.866 g, 80 %) as a dark oil. Used without further purification.

Quellen und Nachweise

ORD-Eintrag
ord-96727602adb24b28af9c737e24f7315c
Quelldatensatz
750 AstraZeneca ELN dataset
Originallink
Quelle ansehen

Verknüpfte Notizen

Wird geladen…